Biological characterization of cold-adapted SARS-CoV-2 variants

Introduction. The emergence of new epidemiologically significant variants of SARS-CoV-2 has shifted emphasis to development of a live vaccine, which would be able to provide protection against a wide range of antigenic variants of the virus. The aim of the study was to obtain SARS-CoV-2 variants...

Full description

Bibliographic Details
Main Authors: Evgeny B. Faizuloev, Ekaterina R. Korchevaya, Anastasiia V. Gracheva, Roman V. Samoilikov, Daria I. Smirnova, Olga S. Sokolova, Grigory S. Glukhov, Andrey V. Moiseenko, Irina A. Leneva, Firaya G. Nagieva, Oksana A. Svitich, Vitaly V. Zverev
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2022-09-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.crie.ru/jour/article/viewFile/1304/747
_version_ 1797629247824592896
author Evgeny B. Faizuloev
Ekaterina R. Korchevaya
Anastasiia V. Gracheva
Roman V. Samoilikov
Daria I. Smirnova
Olga S. Sokolova
Grigory S. Glukhov
Andrey V. Moiseenko
Irina A. Leneva
Firaya G. Nagieva
Oksana A. Svitich
Vitaly V. Zverev
author_facet Evgeny B. Faizuloev
Ekaterina R. Korchevaya
Anastasiia V. Gracheva
Roman V. Samoilikov
Daria I. Smirnova
Olga S. Sokolova
Grigory S. Glukhov
Andrey V. Moiseenko
Irina A. Leneva
Firaya G. Nagieva
Oksana A. Svitich
Vitaly V. Zverev
author_sort Evgeny B. Faizuloev
collection DOAJ
description Introduction. The emergence of new epidemiologically significant variants of SARS-CoV-2 has shifted emphasis to development of a live vaccine, which would be able to provide protection against a wide range of antigenic variants of the virus. The aim of the study was to obtain SARS-CoV-2 variants attenuated through cold adaptation and to provide their biological characterization. Materials and methods. The Dubrovka laboratory strain of SARS-CoV-2 and its variants were cultured on Vero and Calu-3 cells. The virus quantification was performed by virus titration in Vero cells and by real-time reverse transcription-polymerase chain reaction. SARS-CoV-2 virions were analyzed using transmission electron microscopy. Genome sequences of the virus were identified by nanopore sequencing. The attenuation (att) phenotype of SARS-CoV-2 variants was identified using Syrian hamsters as an animal model for COVID-19. Results. Cold-adapted (ca) SARS-CoV-2 variants Dubrovka-ca-B4 and Dubrovka-ca-D2 were produced by continued passaging of the Dubrovka strain in the Vero cell culture at the temperature being gradually decreased to 23C and by subsequent cloning. Up to 20 nucleotide substitutions and 18 amino acid substitutions were detected in genomes of ca-variants. Ca-variants, as distinct from the parent Dubrovka strain, actively replicated at 23C, while the Dubrovka-ca-D2 variant had a temperature-sensitive (ts) phenotype (did not replicate at 39C). Ca-variants of the virus replicated poorly at 37C in the Calu-3 human lung cell culture, which, along with the ts-phenotype, can be a marker of virus attenuation for humans. In the intranasally infected Syrian hamsters, ca-variants of the virus demonstrated an attenuation phenotype: they did not cause loss of appetite, fatigue, drowsiness, did not slow down weight gain, replicating much more slowly in the lungs and brain compared to the virulent Dubrovka strain. Conclusion. The obtained attenuated SARS-CoV-2 ca-variants, Dubrovka-ca-B4 and Dubrovka-ca-D2, should be studied further as candidate vaccine strains for a live attenuated vaccine against COVID-19.
first_indexed 2024-03-11T10:50:37Z
format Article
id doaj.art-11077861b78f48f5874a01ab3ab0511b
institution Directory Open Access Journal
issn 0372-9311
2686-7613
language Russian
last_indexed 2024-03-11T10:50:37Z
publishDate 2022-09-01
publisher Central Research Institute for Epidemiology
record_format Article
series Журнал микробиологии, эпидемиологии и иммунобиологии
spelling doaj.art-11077861b78f48f5874a01ab3ab0511b2023-11-13T17:19:42ZrusCentral Research Institute for EpidemiologyЖурнал микробиологии, эпидемиологии и иммунобиологии0372-93112686-76132022-09-0199439740910.36233/0372-9311-280822Biological characterization of cold-adapted SARS-CoV-2 variantsEvgeny B. Faizuloev0https://orcid.org/0000-0001-7385-5083Ekaterina R. Korchevaya1https://orcid.org/0000-0002-6417-3301Anastasiia V. Gracheva2https://orcid.org/0000-0001-8428-4482Roman V. Samoilikov3https://orcid.org/0000-0001-6405-1390Daria I. Smirnova4https://orcid.org/0000-0001-7325-0834Olga S. Sokolova5https://orcid.org/0000-0003-4678-232XGrigory S. Glukhov6https://orcid.org/0000-0002-9540-8249Andrey V. Moiseenko7https://orcid.org/0000-0003-1112-2356Irina A. Leneva8https://orcid.org/0000-0002-7755-2714Firaya G. Nagieva9https://orcid.org/0000-0001-8204-4899Oksana A. Svitich10https://orcid.org/0000-0003-1757-8389Vitaly V. Zverev11https://orcid.org/0000-0001-5808-2246I.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraLomonosov Moscow State University, Faculty of BiologyLomonosov Moscow State University, Faculty of BiologyLomonosov Moscow State University, Faculty of BiologyI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraIntroduction. The emergence of new epidemiologically significant variants of SARS-CoV-2 has shifted emphasis to development of a live vaccine, which would be able to provide protection against a wide range of antigenic variants of the virus. The aim of the study was to obtain SARS-CoV-2 variants attenuated through cold adaptation and to provide their biological characterization. Materials and methods. The Dubrovka laboratory strain of SARS-CoV-2 and its variants were cultured on Vero and Calu-3 cells. The virus quantification was performed by virus titration in Vero cells and by real-time reverse transcription-polymerase chain reaction. SARS-CoV-2 virions were analyzed using transmission electron microscopy. Genome sequences of the virus were identified by nanopore sequencing. The attenuation (att) phenotype of SARS-CoV-2 variants was identified using Syrian hamsters as an animal model for COVID-19. Results. Cold-adapted (ca) SARS-CoV-2 variants Dubrovka-ca-B4 and Dubrovka-ca-D2 were produced by continued passaging of the Dubrovka strain in the Vero cell culture at the temperature being gradually decreased to 23C and by subsequent cloning. Up to 20 nucleotide substitutions and 18 amino acid substitutions were detected in genomes of ca-variants. Ca-variants, as distinct from the parent Dubrovka strain, actively replicated at 23C, while the Dubrovka-ca-D2 variant had a temperature-sensitive (ts) phenotype (did not replicate at 39C). Ca-variants of the virus replicated poorly at 37C in the Calu-3 human lung cell culture, which, along with the ts-phenotype, can be a marker of virus attenuation for humans. In the intranasally infected Syrian hamsters, ca-variants of the virus demonstrated an attenuation phenotype: they did not cause loss of appetite, fatigue, drowsiness, did not slow down weight gain, replicating much more slowly in the lungs and brain compared to the virulent Dubrovka strain. Conclusion. The obtained attenuated SARS-CoV-2 ca-variants, Dubrovka-ca-B4 and Dubrovka-ca-D2, should be studied further as candidate vaccine strains for a live attenuated vaccine against COVID-19.https://microbiol.crie.ru/jour/article/viewFile/1304/747sars-cov-2cold-adapted virusattenuated virusvaccine strain
spellingShingle Evgeny B. Faizuloev
Ekaterina R. Korchevaya
Anastasiia V. Gracheva
Roman V. Samoilikov
Daria I. Smirnova
Olga S. Sokolova
Grigory S. Glukhov
Andrey V. Moiseenko
Irina A. Leneva
Firaya G. Nagieva
Oksana A. Svitich
Vitaly V. Zverev
Biological characterization of cold-adapted SARS-CoV-2 variants
Журнал микробиологии, эпидемиологии и иммунобиологии
sars-cov-2
cold-adapted virus
attenuated virus
vaccine strain
title Biological characterization of cold-adapted SARS-CoV-2 variants
title_full Biological characterization of cold-adapted SARS-CoV-2 variants
title_fullStr Biological characterization of cold-adapted SARS-CoV-2 variants
title_full_unstemmed Biological characterization of cold-adapted SARS-CoV-2 variants
title_short Biological characterization of cold-adapted SARS-CoV-2 variants
title_sort biological characterization of cold adapted sars cov 2 variants
topic sars-cov-2
cold-adapted virus
attenuated virus
vaccine strain
url https://microbiol.crie.ru/jour/article/viewFile/1304/747
work_keys_str_mv AT evgenybfaizuloev biologicalcharacterizationofcoldadaptedsarscov2variants
AT ekaterinarkorchevaya biologicalcharacterizationofcoldadaptedsarscov2variants
AT anastasiiavgracheva biologicalcharacterizationofcoldadaptedsarscov2variants
AT romanvsamoilikov biologicalcharacterizationofcoldadaptedsarscov2variants
AT dariaismirnova biologicalcharacterizationofcoldadaptedsarscov2variants
AT olgassokolova biologicalcharacterizationofcoldadaptedsarscov2variants
AT grigorysglukhov biologicalcharacterizationofcoldadaptedsarscov2variants
AT andreyvmoiseenko biologicalcharacterizationofcoldadaptedsarscov2variants
AT irinaaleneva biologicalcharacterizationofcoldadaptedsarscov2variants
AT firayagnagieva biologicalcharacterizationofcoldadaptedsarscov2variants
AT oksanaasvitich biologicalcharacterizationofcoldadaptedsarscov2variants
AT vitalyvzverev biologicalcharacterizationofcoldadaptedsarscov2variants